On 2025-05-14, Kalaris Therapeutics Inc. (KLRS) announced earnings per share of $-2.52 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.78.
The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-1.15 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.78 | $-2.52 |
| 2024-11-12 | 2024-09-30 | $-3.22 | $-0.92 |
| 2024-08-09 | 2024-06-30 | $-2.30 | $-1.15 |
| 2024-05-13 | 2024-03-31 | $-3.68 | $-4.14 |
| 2024-03-15 | 2023-12-31 | $-9.89 | $-12.18 |
| 2023-11-02 | 2023-09-30 | $-9.66 | $-8.97 |
| 2023-08-03 | 2023-06-30 | $-10.34 | $-11.03 |
| 2023-05-04 | 2023-03-31 | $-10.80 | $-10.11 |
| 2023-02-15 | 2022-12-31 | $-11.72 | $-8.51 |
| 2022-11-03 | 2022-09-30 | $-11.95 | $-11.49 |
| 2022-08-04 | 2022-06-30 | $-16.09 | $-15.86 |
| 2022-05-05 | 2022-03-31 | $-17.01 | $-15.86 |
| 2022-02-10 | 2021-12-31 | $-16.32 | $-21.15 |
| 2021-11-05 | 2021-09-30 | $-13.56 | $-16.55 |
| 2021-08-06 | 2021-06-30 | $-10.57 | $-13.79 |
| 2021-05-06 | 2021-03-31 | $-9.20 | $-11.49 |
| 2020-11-10 | 2020-09-30 | $-7.59 | $-13.33 |
| 2020-09-02 | 2020-06-30 | $-7.36 | $-101.84 |